Back to Journals » International Journal of Nanomedicine » Volume 11

A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer
Total article views | Abstract views | HTML views | PDF downloads | Totals | |
---|---|---|---|---|---|
9,182 | Dovepress* | 4,808 | 3,273+ | 1,317 | 8,081 |
PubMed Central* | 0 | 1,101 | 311 | 1,101 | |
Totals | 4,808 | 4,374 | 1,628 | 9,182 | |
*Since 8 January 2016 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
8 | 0 | 0 | 0 | 4 | 4 |
View citations on PubMed Central and Google Scholar